Management tracks: GSK adds Corsico, Enzmann to chair CHMP

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) hired Chris Corsico, CMO of Boehringer Ingelheim GmbH (Ingelheim, Germany), to lead all development activities for the pharma. As SVP development, Corsico will be based at GSK’s R&D hub in Stevenage, U.K., and report to Hal Barron, the pharma’s CSO and president of R&D who will serve in the newly created role starting Oct. 1 until Corsico joins in January, GSK spokesperson Mary Anne Rhyne told BioCentury.

GSK's SVP of R&D Pipeline John Lepore will oversee research in the new, parallel role of SVP research beginning Oct. 1, Rhyne added. Lepore is based at the pharma's U.S. R&D hub outside of Philadelphia...